您的位置：
首页
>
农业专利
>
详情页
NOUVELLES UTILISATIONS THERAPEUTIQUES D'INHIBITEURS ENZYMATIQUES
专利权人:
PROXIMAGEN GROUP LIMITED
发明人:
PRITCHARD, MARTYN,RICHARDSON, PETER
申请号：
CA3007776
公开号：
CA3007776A1
申请日:
2016.12.07
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to (R)-carbidopa and pharmaceutical compositionsthereof, and to a combined preparationof (R)-carbidopa and a steroid, and to the use of the same in the treatment orprevention of medical conditions such as pain,inflammatory diseases, immune or autoimmune disorders and tumour growth.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
(R)-CARBIDOPA ALONE OR IN COMBINATION WITH A STEROID FOR TREATING PAIN, INFLAMMATION, AN INFLAMMATORY DISEASE, AN IMMUNE OR AUTOIMMUNE DISEASE AND TUMOUR GROWTH.
(R)-CARBIDOPA ALONE OR IN COMBINATION WITH A STEROID FOR TREATING PAIN, INFLAMMATION, AN INFLAMMATORY DISEASE, AN IMMUNE OR AUTOIMMUNE DISEASE AND TUMOUR GROWTH
(R)-carbidopa alone or in combination with a steroid for treating pain, inflammation, an inflammatory disease, an immune or autoimmune disease and tumour growth.
(R)-carbodopa, which is used alone or in combination with steroids to treat pain, inflammation, inflammatory diseases, immune or autoimmune diseases and tumor growth,
Pyridin-2 (1H) -one derivatives useful for the manufacture of a medicament for the treatment of myeloproliferative diseases, transplant rejection, immune mediated diseases and inflammatory diseases
